Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis - Test2 - elhamkhani - TriplyDB

Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis

Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q28487562

about

Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis The essential mycobacterial genes, fabG1 and fabG4, encode 3-oxoacyl-thioester reductases that are functional in yeast mitochondrial fatty acid synthase type 2 Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum Genomic diversity among Beijing and non-Beijing Mycobacterium tuberculosis isolates from Myanmar The Mycobacterium tuberculosis cytochrome P450 system.Genome-wide transcription analyses in Mycobacterium tuberculosis treated with lupulone.Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients.Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants.Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips.Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.Efflux-mediated antimicrobial resistance.Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo.Role of mycobacterial efflux transporters in drug resistance: an unresolved question.Application of functional genomics to pathway optimization for increased isoprenoid production.Natural product growth inhibitors of Mycobacterium tuberculosis.Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis.Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.Basic concepts of microarrays and potential applications in clinical microbiology.Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.MmpL3 a potential new target for development of novel anti-tuberculosis drugs.Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis.Biochemical Investigation of Rv3404c from Mycobacterium tuberculosis.Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis.AccD6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.Toxicogenomic response of Rhodospirillum rubrum S1H to the micropollutant triclosan Role of long-chain acyl-CoAs in the regulation of mycolic acid biosynthesis in mycobacteria.2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.Triclosan-induced genes Rv1686c-Rv1687c and Rv3161c are not involved in triclosan resistance in Mycobacterium tuberculosis.Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid

P2860

Q21089606-2E882241-DAD6-46D9-BCA3-5D91A312CB22 Q21202793-E21E609D-2F34-4AFF-A42D-D029AC4F5889 Q28473609-E9281974-E334-437B-9C3B-123FCC4BD283 Q28475648-AE63E597-0A30-4DF3-AA8A-CDB829E339A1 Q28475676-A9FF5262-5396-415A-9885-7CDB7DF87B47 Q28487203-7B23005C-E9AD-4EAD-A19F-5AF29F445AEA Q28543543-67154A8E-3DA3-4A48-ABCF-E609BB8E21B1 Q30394670-D4206875-FFD3-4A24-B45A-A494ACE88694 Q33327381-9420AAB5-AC7A-4DF8-9F98-ED2E7B4D0120 Q33615471-7824B298-6E43-48AD-B57D-92ED5ED0EC11 Q33761987-CB0818ED-7FA6-4E69-BCA4-5D1788416F83 Q33770118-04E5ACEE-CDB4-45A1-901F-1EA4398908CF Q33803840-0F8CAC83-980D-4F67-AC5F-0928286B591E Q35012666-00E4589E-A5BD-4C09-BF54-F81FE23E3FB0 Q35153938-B1DA5B62-4A4E-49B3-9C78-C080C29DA9B1 Q35879195-818D5AD7-4FA8-4649-A65F-53A7CD51E7F2 Q35993510-90A6CA76-829B-4ECC-837F-3F5C082A9D3F Q36101770-0AADDB24-3FB4-448B-9E28-3D105AE55D1D Q36138147-5BCC5F0C-24EA-45D7-A4F0-26C0194ABBA8 Q36223232-5CA525D6-2E88-45B3-8A09-2FB0F26C5D10 Q36378353-C3F69CE2-C0A0-4536-B09E-CA690A331063 Q36672684-128B5797-4C76-4703-ACCC-B15C16012E17 Q36772385-03CCB322-AA54-4E01-B9EB-6DD08F2D20BD Q36845726-3E3CD09D-F264-40E1-8B01-1E063845BB06 Q36863134-E066931C-DD69-432F-BE32-228F250C2063 Q37409999-10942787-B9CA-4CBF-ADED-8CA511461D46 Q38097123-88B4B44C-A191-4952-97AA-36FCBCB6F876 Q38170188-A571A16B-2329-4D63-8053-E93AB21F4D04 Q38266496-28C02E34-F9EC-4FEA-9F35-BF94E6E04943 Q38327291-F0BBF716-3CC8-4C23-A16F-C0FE81704377 Q38700240-0E1D7DF6-1C56-4A00-93F1-60734E7DDBC8 Q38989303-F9F5007E-0F92-4AA1-B9CE-EE7ABF5009ED Q39614772-316EEB71-C21B-46E1-BD8A-879067062A70 Q39661161-9C1C3637-82ED-4314-BB7B-8EDA9DD214DB Q39769328-2C008877-B5C7-4682-B4B9-14C60C7EE6A8 Q40752382-F9936CC5-881F-4147-AFC9-31FC97A9CA0A Q41225370-BBB98908-318E-439B-BB26-188497AE5349 Q41293939-D6C05FB3-B302-4CA6-B126-A93CED0688CB Q42046889-8F6B650B-36FD-4422-8627-E4D45854DF06 Q42704871-69BDBF39-0A08-4352-AC28-7AD81F1D9266

P2860

Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis

http://www.wikidata.org/entity/Q28487562

description

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2003

@ast

im September 2003 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2003/09/01)

@sk

vědecký článek publikovaný v roce 2003

@cs

wetenschappelijk artikel (gepubliceerd op 2003/09/01)

@nl

наукова стаття, опублікована у вересні 2003

@uk

مقالة علمية (نشرت في سبتمبر 2003)

@ar

name

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@ast

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@en

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@nl

type

label

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@ast

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@en

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@nl

prefLabel

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@ast

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@en

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@nl

P1433

Q28487562-BBA3E489-F13C-49CD-A06B-57F49F987A9B

P1476

Q28487562-EFE7D6DC-B477-433E-8DDC-7ACA32331BD3

P2093

Q28487562-418C4A15-0255-4CE8-8BB1-D591F1F512A3

Q28487562-457A99CA-AF68-4255-A5E2-45534254489D

Q28487562-502A9A2B-39CC-4BC2-A631-56BD1E90A49C

Q28487562-7C93FFCC-AEC9-4DD3-9508-0227A52AA4AA

Q28487562-A8C38B90-FF20-4630-A7AA-5C63C691899C

Q28487562-EFD26395-2A48-4B85-85B1-68DD2A80D07E

Q28487562-FAE5AF41-1592-44B8-A6A5-63774104750C

P2860

Q28487562-00F30664-7326-45F8-AFC7-33B6398E1B15

Q28487562-0B9E77E9-062D-4CBD-8F1F-89FD15EC7139

Q28487562-2520B6A8-C3A9-46F9-BF43-4AD835CF0398

Q28487562-290A9CB8-C35B-4D22-AF60-4576F91109E4

Q28487562-6D7E5E57-BBA6-406D-81EB-4B462168DA29

Q28487562-8DD14A0E-6D55-4DFD-B990-199E47130377

Q28487562-94EA323A-2827-422E-9109-7382F4DDFAA8

Q28487562-98D3A19F-7A03-4836-A616-FF90B6EA0120

Q28487562-9940988A-1B1F-45E5-989A-8F88D6AB2942

Q28487562-99BC36CE-CC56-4282-9BAC-E03CB3669B97

P304

Q28487562-80029668-A380-4579-84BA-3F8FB4C6D733

P31

Q28487562-2B883D75-6689-4678-90BF-32667E5E49F4

P3181

Q28487562-C7F97D08-AE64-466D-BB2F-E90F0549E433

P356

Q28487562-3DD520A4-3C7E-43DA-8DB2-E8FCEC6F8297

P407

Q28487562-E12A2330-0950-452B-9480-1CE80EEA85EE

P433

Q28487562-A540DDEC-7DE2-48D8-9ACA-98430DDF1F8E

P478

Q28487562-EFE8100A-182A-4B32-BB74-67C3C04A7219

P577

Q28487562-57EB5E00-4EE8-4D6B-B9E8-AFFA446C98B4

P698

Q28487562-29B39822-282C-443D-9E0C-26AB67F4C6E7

P921

Q28487562-2594FEB4-BFEE-4DE1-AD8B-C2995050E876

Q28487562-864BBD49-C64E-4983-8E41-FC8F36BC300F

P932

Q28487562-BD1E180D-05A4-493F-B775-1F8DABA44B88

P3181

P356

AAC.47.9.2903-2913.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

Signature gene expression prof ...... ted Mycobacterium tuberculosis

@en

P2093

Alistair McLaren

http://www.w3.org/2001/XMLSchema#string

Fiona M. Kelly

http://www.w3.org/2001/XMLSchema#string

Joanna C. Betts

http://www.w3.org/2001/XMLSchema#string

Ken Duncan

http://www.w3.org/2001/XMLSchema#string

Mark G. Lennon

http://www.w3.org/2001/XMLSchema#string

Pauline T. Lukey

http://www.w3.org/2001/XMLSchema#string

Steve J. Blakemore

http://www.w3.org/2001/XMLSchema#string

P2860

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

The Envelope of Mycobacteria

Transcriptional regulation and signature patterns revealed by microarray analyses of Streptococcus pneumoniae R6 challenged with sublethal concentrations of translation inhibitors

Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis

Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis

Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis

Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis

Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB

Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

P304

2903–2913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1511054

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.47.9.2903-2913.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12936993

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

Mycobacterium tuberculosis

P932

182614

http://www.w3.org/2001/XMLSchema#string